Alector, Inc.

ALEC Healthcare Biotechnology

Alector, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $21.0 million, down 79.1% from fiscal 2024. In the quarter to June 2026, revenue fell 57.8%, EPS grew 30.0%, free cash flow grew 30.2% and total debt rose 3.27%, each against the same quarter a year earlier.

1.84 0.07 −3.66%
Market cap
$213.3M
P/E
0.0×
Fwd P/E
−1.9×
Dividend yield
—
F-score
1/9
Altman Z
−5.15
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
256.02 413.40 548.86 712.85 735.25 413.31 353.07 290.41 32.45 50.84
Receivables
— — — 2.59 7.39 — — — 200.24 0.22
Total current assets
266.45 424.82 565.81 726.44 749.71 421.51 357.44 293.18 232.97 51.19
Property, Plant, Equpment (Net)
10.84 17.15 21.86 25.52 27.33 30.18 33.85 10.94 2.83 2.54
Goodwill and Intangible Assets (Total)
— — — — — — — — — 0.00
Long-term assets (Other)
2.23 6.39 8.96 7.88 7.05 4.09 2.15 4.25 0.25 0.18
Total non-current assets
26.79 43.49 56.02 61.21 64.95 66.74 64.48 15.18 3.09 —
Total Assets
293.24 468.30 621.83 787.65 814.66 488.25 421.91 308.36 236.06 —
Accounts Payable
1.69 2.22 3.78 4.19 4.75 3.00 0.28 0.13 1.14 1.15
Accrued Expenses
22.97 35.88 35.59 33.33 36.21 33.69 24.96 12.92 7.29 —
Current Part of Debt
0.37 — — 8.06 7.80 7.51 6.57 — — —
Current Part of Capital Lease
— — — — — — — — — 0.00
Current Part of Taxes to Pay
— — — — — — — — — 0.00
Current Revenue (Deferred)
6.68 23.66 82.98 48.23 90.80 23.89 30.17 34.91 18.98 —
Other current liabilities
11.45 48.63 39.44 81.56 127.01 57.57 55.13 47.82 26.26 0.36
Total current liabilities
69.50 125.06 177.95 93.81 139.56 68.09 61.97 47.95 27.40 1.51
Long Term Debt (Total)
9.32 9.39 — 35.27 39.81 43.74 41.47 — — —
Non-current Revenue (Deferred)
164.54 172.17 210.85 443.37 334.42 108.42 123.24 139.72 183.15 0.00
Minority Interests
— — — — — — — — — 0.00
Non-current Liabilities (Other)
1.74 10.51 68.42 0.76 0.16 0.47 0.49 7.57 0.06 0.02
Total non-current liabilities
193.09 216.44 309.72 479.40 374.38 152.63 165.20 147.29 183.21 —
Total liabilities
262.59 341.50 487.67 573.21 513.93 220.72 227.17 195.24 210.61 —
Additional Paid In Capital
1,002.53 955.66 844.04 798.70 748.04 676.96 414.41 17.08 10.15 0.00
Preferred Stock (Total)
— — — — — — — 210.52 77.49 0.00
Common Stock (Net)
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Retained Earnings
(972.06) (829.13) (710.08) (579.69) (446.38) (410.05) (219.82) (114.43) (62.19) (29.71)
Treasury Stock
— — — — — — — — — 0.00
Shareholders Equity (Other)
— — — — — — — — — 0.00
Common Equity (Total)
30.65 126.80 134.16 214.44 300.72 267.53 194.74 (97.40) (52.03) (24.91)
Shareholders Equity (Total)
30.65 126.80 134.16 214.44 300.72 267.53 194.74 113.12 25.45 —
Shareholders Equity and Liabilities (Total)
293.24 468.30 621.83 787.65 814.66 488.25 421.91 308.36 236.06 —
Shares (Common)
110.36 99.09 84.88 82.90 81.99 79.32 69.05 13.77 13.78 —
Shareholders Equity (Tangible)
30.65 126.80 134.16 214.44 300.72 267.53 194.74 113.12 25.45 —
Net Debt
(246.33) (404.01) (548.86) (669.52) (687.65) (362.05) (305.04) (290.41) (32.45) (50.84)
Total Debt
9.69 9.39 — 43.33 47.60 51.26 48.04 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates